Skip to content
healthcare.dev

Beleodaq

NDC 72893-002, Belinostat, injection, powder, lyophilized, for solution, from Acrotech Biopharma Inc.

Product NDC
72893-002
Status
Listed
Labeler
Acrotech Biopharma Inc
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA206256
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/72893-002 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BELINOSTAT500 mg/10mL

Pharmacologic classes

Histone Deacetylase Inhibitor [EPC]; Histone Deacetylase Inhibitors [MoA]

Package NDCNDC-11Package
72893-002-01728930002011 VIAL in 1 CARTON (72893-002-01) / 10 mL in 1 VIAL

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/2e8ef36b-71fa-4492-a16f-577d5f7d111d
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=72893-002

Use it

Look up 72893-002 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/72893-002 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 72893-002. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.